Long‐Term Entecavir Treatment Results in Sustained Antiviral Efficacy and Prolonged Life Span in the Woodchuck Model of Chronic Hepatitis Infection

Richard J. Colonno, Eugene V. Genovesi, Ivette Medina, +9

The Journal of Infectious Diseases

Orally Active Fusion Inhibitor of Respiratory Syncytial Virus

Christopher Cianci, Kuo‐Long Yu, Keith D. Combrink, +21

Antimicrobial Agents and Chemotherapy

Oral Efficacy of a Respiratory Syncytial Virus Inhibitor in Rodent Models of Infection

Christopher Cianci, Eugene V. Genovesi, Lucinda Lamb, +13

Antimicrobial Agents and Chemotherapy

ImmunologyOral EfficacyAntiviral DrugAntiviral Drug DevelopmentInfection Control +14

Respiratory syncytial virus fusion inhibitors. Part 4: Optimization for oral bioavailability

Kuo‐Long Yu, Ny Sin, Rita L. Civiello, +21

Bioorganic & Medicinal Chemistry Letters

Oral BioavailabilityMedicineAntiviral Drug DevelopmentAntiviral ResponseAntiviral Therapy +4

Enterococcal virulence determinants may be involved in resistance to clinical therapy

Andrea Marra, Fadia B. Dib-Hajj, Lucinda Lamb, +6

Diagnostic Microbiology and Infectious Disease

Antimicrobial Resistance GeneAntimicrobial SusceptibilityHealth SciencesEnterococcal Virulence DeterminantsVirulence Factor +10

Respiratory syncytial virus fusion inhibitors. Part 7: Structure–activity relationships associated with a series of isatin oximes that demonstrate antiviral activity in vivo

Ny Sin, Brian L. Venables, Keith D. Combrink, +16

Bioorganic & Medicinal Chemistry Letters

Antiviral ActivityMedicineImmunologyAntiviral ResponseMolecular Biology +10

In Vitro and In Vivo Activities of a Novel Cephalosporin, BMS-247243, against Methicillin-Resistant and -Susceptible Staphylococci

J Fung-Tomc, Junius M. Clark, Beatrice Minassian, +11

Antimicrobial Agents and Chemotherapy

Respiratory syncytial virus fusion inhibitors. Part 3: Water-soluble benzimidazol-2-one derivatives with antiviral activity in vivo

Kuo‐Long Yu, Xiangdong Alan Wang, Rita L. Civiello, +15

Bioorganic & Medicinal Chemistry Letters

Water-soluble Benzimidazol-2-one DerivativesAntiviral ActivityMedicineImmunologyAntiviral Drug Development +7

Respiratory syncytial virus fusion inhibitors. Part 6: An examination of the effect of structural variation of the benzimidazol-2-one heterocycle moiety

Keith D. Combrink, H. Belgin Gülgeze, Jan Willem Thuring, +17

Bioorganic & Medicinal Chemistry Letters

Virus StructureStructural VariationMedicineAntiviral Drug DevelopmentMolecular Biology +6

Effect of Linezolid on the 50% Lethal Dose and 50% Protective Dose in Treatment of Infections by Gram-Negative Pathogens in Naive and Immunosuppressed Mice and on the Efficacy of Ciprofloxacin in an Acute Murine Model of Septicemia

Andrea Marra, Lucinda Lamb, Ivette Medina, +6

Antimicrobial Agents and Chemotherapy

Antiparasitic AgentAntibiotic AdjuvantKlebsiella PneumoniaeAntimicrobial ChemotherapyDrug Resistance +16